Skip to content

The effect of muscle stimulation and amino acid intake on protein metabolism during critical illness (SPICE I)

The effect of a single session of whole-body neuromuscular electrical stimulation (NMES), with or without subsequent intake of an amino acid bolus, on whole-body protein turnover in sedated intensive care unit (ICU) patients - Short NMES and protein intake on WB protein turnover in ICU (SPICE I)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57151
Enrollment
30
Registered
2024-07-05
Start date
2025-09-15
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin resistance

Interventions

A single test day during which participants will either receive sham-NMES followed by standard enteral nutrition (CON), whole-body NMES stimulation followed by standard enteral nutrition (WB-NMES), or

Sponsors

Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Aged >=18 years • Expected to need mechanical ventilation for at least 48 hours, judged by physician • Expected to reach a Richmond Agitation-Sedation Scale (RASS) score of -4 or -5 (complete sedation), judged by physician • Informed consent obtained from the next-of-kin • Able to or are receiving enteral nutrition • Have an arterial and a venous line

Exclusion criteria

Exclusion criteria: • Spinal cord injury • Previous surgery/local wounds that prohibit NMES • Conditions that prohibit NMES (such as open wounds) • Chronic neuromuscular disorders • Acute Kidney Injury (AKI) II and III • Undergoing continuous veno-venous hemofiltration (CVVH) • Rhabdomyolysis (based on plasma creatine kinase levels) • Neuromuscular blocking agents • In the caloric restriction period of refeeding syndrome • In prone position • Burn wounds • ICD/pacemaker • Pregnant • Deemed not suitable to participate based upon the judgement of the treating intensivist

Design outcomes

Primary

MeasureTime frame
Whole-body protein net balance (WPNB)

Secondary

MeasureTime frame
Whole body protein synthesis, breakdown, and oxidation. Forearm muscle glucoseuptake (i.e. a direct measure of muscle insulin sensitivity).

Countries

Netherlands

Contacts

Public ContactM.L. Dirks

Wageningen Universiteit

marlou.dirks@wur.nl+31317484136

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 11, 2026